dMed Biopharmaceutical Co., Ltd.

The Chinese pharma industry has reached a historic turning point in the era of innovation, filled with opportunities and challenges. Clinical trials must be implemented in accordance with international standards at the highest quality.

dMed has emerged as a distinctive provider with a strong sense of ownership and collaboration to help drug developers accelerate progress and improve their success rates.